Reading view
PanLUNA: An Efficient and Robust Query-Unified Multimodal Model for Edge Biosignal Intelligence
SLaB: Sparse-Lowrank-Binary Decomposition for Efficient Large Language Models
FileGram: Grounding Agent Personalization in File-System Behavioral Traces
Self-Improving Pretraining: using post-trained models to pretrain better models
Interpretable machine learning models for stroke risk prediction in patients with newly diagnosed atrial fibrillation
npj Digital Medicine, Published online: 07 April 2026; doi:10.1038/s41746-026-02470-3
Interpretable machine learning models for stroke risk prediction in patients with newly diagnosed atrial fibrillationSpliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancer
Oncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03764-2
Spliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancerEfficient amyloid-β degradation in Alzheimer’s disease using SPYTACs
FA-INR: Adaptive Implicit Neural Representations for Interpretable Exploration of Simulation Ensembles
SARE: Sample-wise Adaptive Reasoning for Training-free Fine-grained Visual Recognition
A Review of the Role of Zeqi Decoction in the Treatment of Non-Small Cell Lung Cancer
J Multidiscip Healthc. 2026 Mar 11;19:584071. doi: 10.2147/JMDH.S584071. eCollection 2026.
ABSTRACT
Non-small cell lung cancer (NSCLC) is one of the malignant tumors with the highest incidence and mortality rates. Zeqi Decoction has the functions of "promoting diuresis and reducing swelling, resolving phlegm and dispersing nodules", embodying the unique approach of traditional Chinese medicine in treating lung cancer by "strengthening the body's resistance and eliminating pathogenic factors". Modern research shows that Zeqi Decoction exerts anti-NSCLC effects through multiple pathways and targets. In terms of the material basis of its efficacy, its active ingredients (such as diterpene esters and flavonoids contained in Zeqi) have the ability to directly inhibit the proliferation, invasion and migration of tumor cells and induce apoptosis. In terms of the mechanism of action, basic experiments have revealed that Zeqi Decoction can down-regulate the S100A9/STAT3 signaling pathway, inhibit the immunosuppressive activity of myelium-derived suppressor cells (MDSCs), reshape the tumor microenvironment, thereby enhancing the cytotoxic function of CD8⁺T cells, and can also regulate the EGFR/PI3K/Akt pathway to affect PD-L1 expression. Intervene in tumor immune escape; In terms of clinical transformation, the combination of Zexi Decoction with chemotherapy and targeted therapy can improve patients' symptoms such as cough and pleural effusion, prolong progression-free survival, and alleviate the toxic and side effects of Western medical treatment. In addition, Zexi Decoction also shows potential value in reversing drug resistance such as gemcitabine. At present, there are still problems such as the lack of standardized protocols and unclear molecular mechanisms in the research. In the future, it is necessary to combine new technologies such as network pharmacology and multi-omics analysis to deepen the research on the pharmacological material basis, dose-effect relationship and evidence-based medicine of Zeqi Decoction, so as to promote the clinical application and transformation of the combination of traditional Chinese and Western medicine in the treatment of NSCLC.
PMID:41847115 | PMC:PMC12991379 | DOI:10.2147/JMDH.S584071
FedBPrompt: Federated Domain Generalization Person Re-Identification via Body Distribution Aware Visual Prompts
GeoChemAD: Benchmarking Unsupervised Geochemical Anomaly Detection for Mineral Exploration
OpenSage: Self-programming Agent Generation Engine
Superficial Safety Alignment Hypothesis
LatentChem: From Textual CoT to Latent Thinking in Chemical Reasoning
Author Correction: Gut stem cell necroptosis by genome instability triggers bowel inflammation
Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10302-3
Author Correction: Gut stem cell necroptosis by genome instability triggers bowel inflammationQuantifying endosomal escape in vivo to guide lipid nanoparticle design
Nature Biotechnology, Published online: 11 March 2026; doi:10.1038/s41587-026-03047-x
A lysosomal barcoding strategy to quantify endosomal escape of nucleic acids in vivo assesses the performance of branched ionizable lipids for potent liver delivery.